Safely and effectively prescribe today's full spectrum of topical, intralesional, and systemic drugs for dermatologic disorders! Dr. Steven E. Wolverton and a team of leading international experts explain what drugs to use, when to use them...and what to watch out for. Handheld software - included with the book - provides full-text explanations as well as at-a-glance summaries of key pharmacologic information, instantly accessible wherever and whenever questions about skin pharmaceuticals arise. Provides at-a-glance access to key information including summaries of indications/contraindications, dosage guidelines, drug interactions, drug monitoring guidelines, adverse effects, and treatment protocols. Features a consistent organization throughout to expedite fast reference. Provides purchase information for major drugs, to help you and your patients. Includes a highly detailed, disease-specific index, helping you to evaluate drug options for each disease discussed. .Highlights key controversies and provides expert guidance in a Question and Answer feature. Presents new chapters on TNF Inhibitors, Signal II Cytokine Inhibitors, Pimicrolimus, IV Immunoglobulin, Drug-Induced Malignancies, Polymorphisms, and non-dermatologic drugs related to dermatologic problems. Features updates on new drug findings and new research, especially findings on predicting an individual response to drugs on the basis of ethnicity and gender.27 Schneider M, Stahl H-D, Podrebarac T, et al. Tolerability and ... 2004;50(Suppl 3):P226. 28 Heffernan MP ... Available at: URL:http://www.fda.gov/cder/ biologics/ review/alefbio013003r2p1.pdf 37 Lowe NJ, Gonzalez J, Bagel J, et al. Repeat.
|Title||:||Comprehensive Dermatologic Drug Therapy|
|Author||:||Stephen E. Wolverton|
|Publisher||:||Elsevier Health Sciences - 2007-03-08|